Subscribe to eTOC

Efgartigimod Was Well-Tolerated in Patients with Generalized Myasthenia Gravis

April 26, 2021

Neurology Today At the American Academy of Neurology Annual Meeting: ​Efgartigimod was safe and effective for patients with generalized myasthenia gravis. Neurology Today Editor-in-Chief Joseph E. Safdieh interviews James F. Howard Jr, MD, FAAN, professor of neurology at the University of North Carolina in Chapel Hill, about the clinical implications of the research. Read the full report:

Recent Videos